Collectively, these findings indicate that genetic variants that abolish ANGPTL4 function are associated with improved insulin sensitivity and glucose homeostasis and reduced risk of type 2 diabetes in humans. The gene discussed is INS; the disease is type 2 diabetes mellitus.